Polycystic Ovary Syndrome (Investigational Adjunct)

Resumen para el Paciente

¿Está esto autorizado por FDA para este uso?

Not FDA-cleared for polycystic ovary syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is highly investigational.

¿Qué evidencia existe?

Tier C (investigational). Only anecdotal case reports; there are no randomized controlled trials. Evidence-based management per ESHRE 2023 international guideline includes lifestyle modification (the cornerstone for overweight or obese patients — even modest weight loss restores ovulation), combined hormonal contraception for menstrual regulation and hyperandrogenism (acne, hirsutism), metformin for insulin resistance and ovulation, anti-androgens (spironolactone) for hyperandrogenism, and letrozole or clomiphene for fertility-seeking patients.

Riesgos principales

• Bleeding from bite sites for 6 to 24 hours after detachment
• Bruising and tenderness over the lower abdomen and sacrum for 5 to 10 days
• Local skin infection or, rarely, Aeromonas infection
• Allergic reaction to leech saliva (uncommon)
• Worsening anemia, especially in patients with menstrual irregularity or chronic anovulation
• Hypoglycemia risk if on metformin and significant blood loss occurs
• Delay or replacement of evidence-based lifestyle and pharmacotherapy
• Missed diagnosis of endometrial hyperplasia or carcinoma in untreated chronic anovulation

Quién no debería considerar esto

• Patients who are pregnant or in an IVF cycle
• Patients with insulin-resistance-related anemia or severe nutritional deficiency
• Patients with combined hormonal contraception use and VTE risk factors (smoking over age 35, migraine with aura)
• Patients with endometrial hyperplasia or unexplained postmenopausal-pattern bleeding needing evaluation
• Patients on anticoagulants, with hemophilia, or with severe anemia
• Patients who have not been screened for diabetes, dyslipidemia, OSA, or NAFLD (PCOS metabolic comorbidities)

Qué preguntar a su clínico

• Has my diagnosis been confirmed per Rotterdam Criteria (2 of 3: oligo / anovulation, hyperandrogenism, polycystic ovaries)?
• Have I been screened for diabetes (OGTT or HbA1c), dyslipidemia, OSA, and NAFLD?
• Have I tried evidence-based lifestyle modification (5 to 10 percent weight loss restores ovulation in many patients)?
• Am I on appropriate hormonal contraception, metformin, or anti-androgens?
• If fertility is the goal, have I been offered letrozole or clomiphene with proper monitoring?
• What is the practitioner's experience and Aeromonas-prevention plan?
• Where exactly will leeches be placed — NEVER intravaginally?

Cuándo buscar atención urgente

• Heavy unexplained bleeding (consider endometrial hyperplasia or pregnancy-related issue)
• Sudden severe pelvic pain (possible ovarian torsion or ruptured cyst)
• Sudden one-sided leg swelling, redness, pain (DVT — combined hormonal contraception adds risk)
• Sudden chest pain, shortness of breath, or stroke-like symptoms (thromboembolic event)
• Severe nausea, vomiting, or abdominal pain (possible diabetic ketoacidosis, hyperosmolar state)
• Bleeding from a bite site lasting more than 24 to 48 hours
• Fever above 38.0 C / 100.4 F or chills
• Hives, throat tightness, or breathing difficulty